152 related articles for article (PubMed ID: 15215146)
1. Rhesus cytomegalovirus is similar to human cytomegalovirus in susceptibility to benzimidazole nucleosides.
North TW; Sequar G; Townsend LB; Drach JC; Barry PA
Antimicrob Agents Chemother; 2004 Jul; 48(7):2760-5. PubMed ID: 15215146
[TBL] [Abstract][Full Text] [Related]
2. Resistance of human cytomegalovirus to benzimidazole ribonucleosides maps to two open reading frames: UL89 and UL56.
Krosky PM; Underwood MR; Turk SR; Feng KW; Jain RK; Ptak RG; Westerman AC; Biron KK; Townsend LB; Drach JC
J Virol; 1998 Jun; 72(6):4721-8. PubMed ID: 9573236
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of human cytomegalovirus replication by benzimidazole nucleosides involves three distinct mechanisms.
Evers DL; Komazin G; Ptak RG; Shin D; Emmer BT; Townsend LB; Drach JC
Antimicrob Agents Chemother; 2004 Oct; 48(10):3918-27. PubMed ID: 15388453
[TBL] [Abstract][Full Text] [Related]
4. Characterization of rhesus cytomegalovirus genes associated with anti-viral susceptibility.
Swanson R; Bergquam E; Wong SW
Virology; 1998 Jan; 240(2):338-48. PubMed ID: 9454707
[TBL] [Abstract][Full Text] [Related]
5. Role of a mutation in human cytomegalovirus gene UL104 in resistance to benzimidazole ribonucleosides.
Komazin G; Townsend LB; Drach JC
J Virol; 2004 Jan; 78(2):710-5. PubMed ID: 14694102
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of fluorosugar analogues of 2,5,6-trichloro-1-(beta-D-ribofuranosyl)benzimidazole as antivirals with potentially increased glycosidic bond stability.
Gudmundsson KS; Freeman GA; Drach JC; Townsend LB
J Med Chem; 2000 Jun; 43(12):2473-8. PubMed ID: 10882375
[TBL] [Abstract][Full Text] [Related]
7. Phosphorylation of beta-D-ribosylbenzimidazoles is not required for activity against human cytomegalovirus.
Krosky PM; Borysko KZ; Nassiri MR; Devivar RV; Ptak RG; Davis MG; Biron KK; Townsend LB; Drach JC
Antimicrob Agents Chemother; 2002 Feb; 46(2):478-86. PubMed ID: 11796361
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and antiviral evaluation of trisubstituted indole N-nucleosides as analogues of 2,5,6-trichloro-1-(beta-D-ribofuranosyl)benzimidazole (TCRB).
Chen JJ; Wei Y; Drach JC; Townsend LB
J Med Chem; 2000 Jun; 43(12):2449-56. PubMed ID: 10882372
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and antiviral evaluation of halogenated beta-D- and -L-erythrofuranosylbenzimidazoles.
Gudmundsson KS; Tidwell J; Lippa N; Koszalka GW; van Draanen N; Ptak RG; Drach JC; Townsend LB
J Med Chem; 2000 Jun; 43(12):2464-72. PubMed ID: 10882374
[TBL] [Abstract][Full Text] [Related]
10. Benzimidazole 2'-isonucleosides: design, synthesis, and antiviral activity of 2-substituted-5,6-dichlorobenzimidazole 2'-isonucleosides.
Freeman GA; Selleseth DW; Rideout JL; Harvey RJ
Nucleosides Nucleotides Nucleic Acids; 2000; 19(1-2):155-74. PubMed ID: 10772707
[TBL] [Abstract][Full Text] [Related]
11. Resistance of human cytomegalovirus to the benzimidazole L-ribonucleoside maribavir maps to UL27.
Komazin G; Ptak RG; Emmer BT; Townsend LB; Drach JC
J Virol; 2003 Nov; 77(21):11499-506. PubMed ID: 14557635
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and antiviral evaluation of polyhalogenated imidazole nucleosides: dimensional analogues of 2,5,6-trichloro-1-(beta-D-ribofuranosyl)benzimidazole.
Chien TC; Saluja SS; Drach JC; Townsend LB
J Med Chem; 2004 Nov; 47(23):5743-52. PubMed ID: 15509173
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis, and antiviral activity of alpha-nucleosides: D- and L-isomers of lyxofuranosyl- and (5-deoxylyxofuranosyl)benzimidazoles.
Migawa MT; Girardet JL; Walker JA; Koszalka GW; Chamberlain SD; Drach JC; Townsend LB
J Med Chem; 1998 Apr; 41(8):1242-51. PubMed ID: 9575044
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis, and antiviral evaluation of 2-deoxy-D-ribosides of substituted benzimidazoles as potential agents for human cytomegalovirus infections.
Zou R; Kawashima E; Freeman GA; Koszalka GW; Drach JC; Townsend LB
Nucleosides Nucleotides Nucleic Acids; 2000; 19(1-2):125-53. PubMed ID: 10772706
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis, and biological evaluation of tricyclic nucleosides (dimensional probes) as analogues of certain antiviral polyhalogenated benzimidazole ribonucleosides.
Zhu Z; Lippa B; Drach JC; Townsend LB
J Med Chem; 2000 Jun; 43(12):2430-7. PubMed ID: 10882370
[TBL] [Abstract][Full Text] [Related]
16. Human cytomegalovirus resistance to deoxyribosylindole nucleosides maps to a transversion mutation in the terminase subunit-encoding gene UL89.
Gentry BG; Phan Q; Hall ED; Breitenbach JM; Borysko KZ; Kamil JP; Townsend LB; Drach JC
Antimicrob Agents Chemother; 2015 Jan; 59(1):226-32. PubMed ID: 25348532
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis, and antiviral evaluation of some polyhalogenated indole C-nucleosides.
Chen JJ; Wei Y; Williams JD; Drach JC; Townsend LB
Nucleosides Nucleotides Nucleic Acids; 2005; 24(10-12):1417-37. PubMed ID: 16438026
[TBL] [Abstract][Full Text] [Related]
18. Convergent synthesis of polyhalogenated quinoline C-nucleosides as potential antiviral agents.
Chen JJ; Drach JC; Townsend LB
J Org Chem; 2003 May; 68(11):4170-8. PubMed ID: 12762715
[TBL] [Abstract][Full Text] [Related]
19. Comparison of benzimidazole nucleosides and ganciclovir on the in vitro proliferation and colony formation of human bone marrow progenitor cells.
Nassiri MR; Emerson SG; Devivar RV; Townsend LB; Drach JC; Taichman RS
Br J Haematol; 1996 May; 93(2):273-9. PubMed ID: 8639416
[TBL] [Abstract][Full Text] [Related]
20. Studies designed to increase the stability and antiviral activity (HCMV) of the active benzimidazole nucleoside, TCRB.
Townsend LB; Gudmundsson KS; Daluge SM; Chen JJ; Zhu Z; Koszalka GW; Boyd L; Chamberlain SD; Freeman GA; Biron KK; Drach JC
Nucleosides Nucleotides; 1999; 18(4-5):509-19. PubMed ID: 10432642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
